TXMD

NASDAQStock

TherapeuticsMD, Inc.

$2.20-0.08 (-3.51%)

52-Week Range

$0.73

$2.77

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

0.54

Volume

18.4K

Avg Volume

22.4K

Performance

-5.79%

+34.12%

+111.11%

YTD

+38.18%

+214.40%

-37.53%

-97.25%

Price Chart

ETF Exposure

TXMD is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	12	$35	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	429	$1K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	2	$6	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	244,317	$528K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	1,285	$4K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	110	$324	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	90,875	$196K	$84.10B	0.05%

About TXMD ETF Exposure

TherapeuticsMD, Inc. (TXMD) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $2.20. Investors can gain exposure to TXMD through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TXMD, sorted by portfolio weight.